![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Johnson Matthew P Fernandez Francesca Colson Natalie J Griffiths Lyn R
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.8, Iss.12, 2007-08, pp. : 1821-1835
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomic considerations for immunosuppressive therapy
Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomic approaches that may guide preeclampsia therapy
By Luizon Marcelo R Sandrim Valeria C
Pharmacogenomics, Vol. 14, Iss. 6, 2013-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children
Current Medicinal Chemistry, Vol. 20, Iss. 17, 2013-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Migraine During Pregnancy: Options for Therapy
CNS Drugs, Vol. 19, Iss. 6, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
An Economic Evaluation of Rizatriptan in the Treatment of Migraine
PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. :